“Long-Term Efficacy and Safety of Ritlecitinib in Adults and Adolescents With Alopecia Areata: 3-Year Results from the ALLEGRO-LT Phase 3, Open-Label Study”. 2025. SKIN The Journal of Cutaneous Medicine 9 (4): s582. https://doi.org/10.25251/gdd40x24.